Incyte today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19 ...
Ten years ago, 15-year-old Pranav Dhanawade etched his name in cricket history with an unbeaten 1009 in a Mumbai school match ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback